Literature DB >> 3728501

Body stature as a risk factor for diabetic sensory neuropathy.

J M Sosenko, M T Gadia, A M Fournier, M T O'Connell, M C Aguiar, J S Skyler.   

Abstract

Risk factors for vibratory perception threshold abnormalities were studied in 200 diabetic patients between the ages of 21 and 70 years and 62 control subjects of similar age. Vibratory perception (measured with the Biothesiometer) was absent over one or both halluces in 18 percent of the patients. In a stepwise multiple logistic regression analysis, height was the variable most strongly associated with absent vibratory perception (coefficient +/- SE, 0.501 +/- 0.097/inch; p less than 0.0001). Duration of diabetes (p less than 0.001), age (p less than 0.05), and ethanol use (p less than 0.05) were also associated. The prevalence of absent vibratory perception in the lower, middle, and upper thirds of the height distribution was 0.05, 0.08, and 0.40, respectively. Among the control subjects, there was no association of vibratory perception with either height or ethanol use. These data strongly suggest that body stature is a major risk factor for diabetic sensory neuropathy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3728501     DOI: 10.1016/0002-9343(86)90661-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

Review 1.  The prevalence of diabetic neuropathy according to ethnicity.

Authors:  Jay M Sosenko
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

2.  Peripheral insensate neuropathy-is height a risk factor?

Authors:  G S Sharath Kote; Ajay N Bhat; Thajuddeen K; Mohammed H Ismail; Abhishek Gupta
Journal:  J Clin Diagn Res       Date:  2012-12-24

3.  Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor?

Authors:  Chin-Hsiao Tseng
Journal:  CMAJ       Date:  2006-01-31       Impact factor: 8.262

4.  Subclinical nerve dysfunction in children and adolescents with IDDM.

Authors:  L Hyllienmark; T Brismar; J Ludvigsson
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

5.  Selected RANKL/RANK/OPG system genetic variants in diabetic foot patients.

Authors:  Beata Mrozikiewicz-Rakowska; Piotr Nehring; Konrad Szymański; Agnieszka Sobczyk-Kopcioł; Rafał Płoski; Wojciech Drygas; Janusz Krzymień; Nikita Amit Acharya; Leszek Czupryniak; Adam Przybyłkowski
Journal:  J Diabetes Metab Disord       Date:  2018-11-09

6.  Potential risk factors for diabetic neuropathy: a case control study.

Authors:  Fargol Booya; Fatemeh Bandarian; Bagher Larijani; Mohammad Pajouhi; Mahdi Nooraei; Jamshid Lotfi
Journal:  BMC Neurol       Date:  2005-12-10       Impact factor: 2.474

7.  Diabetic foot risk factors in type 2 diabetes patients: a cross-sectional case control study.

Authors:  Piotr Nehring; Beata Mrozikiewicz-Rakowska; Monika Krzyżewska; Agnieszka Sobczyk-Kopcioł; Rafał Płoski; Grażyna Broda; Waldemar Karnafel
Journal:  J Diabetes Metab Disord       Date:  2014-08-04

8.  Prevalence and Determinants of Painful and Painless Neuropathy in Type 1 Diabetes Mellitus.

Authors:  Margarida Barbosa; Ana Saavedra; Sofia Oliveira; Ligia Reis; Filipa Rodrigues; Milton Severo; Reinhard Sittl; Christoph Maier; Davide M Carvalho
Journal:  Front Endocrinol (Lausanne)       Date:  2019-06-28       Impact factor: 5.555

9.  Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.

Authors:  Johan Wadén; Carol Forsblom; Lena M Thorn; Markku Saraheimo; Milla Rosengård-Bärlund; Outi Heikkilä; Kustaa Hietala; Ken Ong; Nicholas Wareham; Per-Henrik Groop
Journal:  Diabetes       Date:  2009-06-02       Impact factor: 9.461

10.  Protection from clinical peripheral sensory neuropathy in Alström syndrome in contrast to early-onset type 2 diabetes.

Authors:  Richard B Paisey; Rosamund M Paisey; Mary P Thomson; Lynne Bower; Pietro Maffei; Julian P H Shield; Sue Barnett; Jan D Marshall
Journal:  Diabetes Care       Date:  2008-12-17       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.